|
06 Nov 2007 |
Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at Society for Neuroscience Meeting
|
|
06 Nov 2007 |
Advanced Cell Technology's Chief Scientific Officer Featured Speaker at American College of Rheumatology/ Association of Rheumatology Health Professionals
|
|
05 Nov 2007 |
Sangamo BioSciences Presents Positive Data Showing Pain Reduction by Novel ZFP Therapeutic at Society for Neuroscience Meeting
|
|
30 Oct 2007 |
BioAlliance Pharma's New Entity, AMEP, shows anti-angiogenic and antiproliferative activity in vitro and in vivo
|
|
26 Oct 2007 |
Genzyme and Sunway to Collaborate on Gene Therapy Program in China
|
|
26 Oct 2007 |
Osiris Therapeutics Initiates Phase II Clinical Trial Evaluating Prochymal(TM) for Type 1 Diabetes
|
|
24 Oct 2007 |
Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
|
|
19 Oct 2007 |
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
|
|
19 Oct 2007 |
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
|
|
18 Oct 2007 |
Alnylam and Collaborators Publish New Pre-clinical Results on RNAi Therapeutics for the Treatment of Huntington's Disease
|
|
18 Oct 2007 |
Osiris Therapeutics Receives FDA Clearance to Initiate Phase III Pivotal Trial for Prochymal (TM) as a First Line Treatment for Acute Graft vs. Host Disease
|
|
12 Oct 2007 |
Hemispherx Biopharma Files New Drug Application for Ampligen(R)
|
|
09 Oct 2007 |
Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
|
|
09 Oct 2007 |
Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
|
|
06 Oct 2007 |
Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months
|
|
06 Oct 2007 |
AVONTEC's drug candidate AVT-02 UE for the treatment of inflammatory skin diseases has entered a multiple dosing Phase I study
|
|
05 Oct 2007 |
Aastrom Announces Positive Interim Results From Phase I/II Study Involving Use of Vascular Repair Cells in Patients With Critical Limb Ischemia
|
|
05 Oct 2007 |
Isis Reports Positive Results of Phase 2 Study of ISIS 301012 in Heterozygous FH Patients
|
|
03 Oct 2007 |
Aegera Therapeutics Initiates Four Phase I/II Clinical Trials for AEG35156
|
|
02 Oct 2007 |
Transgene Extends Therapeutic Vaccine Candidate TG4040 Development Program Against Chronic Hepatitis C
|
|
25 Sep 2007 |
Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
|
|
21 Sep 2007 |
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
|
|
21 Sep 2007 |
GenVec Technology Demonstrates Selective Anti-Cancer Activity
|
|
19 Sep 2007 |
Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
|
|
19 Sep 2007 |
VIRxSYS Presents Update on HIV Gene Therapy Clinical Trial at ICAAC
|
